Is Astrana Health Stock a Good Investment?
Astrana Health Investment Advice | ASTH |
- Examine Astrana Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Astrana Health's leadership team and their track record. Good management can help Astrana Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Astrana Health's business and its evolving consumer preferences.
- Compare Astrana Health's performance and market position to its competitors. Analyze how Astrana Health is positioned in terms of product offerings, innovation, and market share.
- Check if Astrana Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Astrana Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Astrana Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Astrana Health is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Small | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Astrana Health Stock
Researching Astrana Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 24.0% of the company shares are held by company insiders. The book value of Astrana Health was presently reported as 14.75. The company had not issued any dividends in recent years. Astrana Health had 1:10 split on the 27th of April 2015.
To determine if Astrana Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Astrana Health's research are outlined below:
| Astrana Health generated a negative expected return over the last 90 days | |
| Astrana Health has high historical volatility and very poor performance | |
| Astrana Health is unlikely to experience financial distress in the next 2 years | |
| Astrana Health was previously known as Astrana Health and was traded on NASDAQ Exchange under the symbol AMEH. | |
| About 24.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Disposition of 3409 shares by Kitayama Mitchell W of Astrana Health at 18.41 subject to Rule 16b-3 |
Earnings surprises can significantly impact Astrana Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Astrana Health's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-03-12 | 2019-12-31 | 0.2 | 0.18 | -0.02 | 10 | ||
2023-08-07 | 2023-06-30 | 0.25 | 0.28 | 0.03 | 12 | ||
2023-02-23 | 2022-12-31 | -0.09 | -0.06 | 0.03 | 33 | ||
2022-02-24 | 2021-12-31 | 0.27 | 0.3 | 0.03 | 11 | ||
2018-08-14 | 2018-06-30 | 0.1 | 0.07 | -0.03 | 30 | ||
2019-11-07 | 2019-09-30 | 0.14 | 0.1 | -0.04 | 28 | ||
2019-08-09 | 2019-06-30 | 0.05 | 0.09 | 0.04 | 80 | ||
2022-08-04 | 2022-06-30 | 0.2 | 0.25 | 0.05 | 25 |
Know Astrana Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Astrana Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Astrana Health backward and forwards among themselves. Astrana Health's institutional investor refers to the entity that pools money to purchase Astrana Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-09-30 | 424.1 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 342.6 K | Fort Washington Investment Advisors Inc | 2024-09-30 | 299.8 K | Bank Of New York Mellon Corp | 2024-09-30 | 268.7 K | Goldman Sachs Group Inc | 2024-09-30 | 258.9 K | Royal Bank Of Canada | 2024-09-30 | 254.6 K | Bellevue Group Ag | 2024-09-30 | 254.2 K | Amvescap Plc. | 2024-09-30 | 241.8 K | Atria Wealth Solutions, Inc. | 2024-09-30 | 237.4 K | Blackrock Inc | 2024-06-30 | 6.4 M | Vanguard Group Inc | 2024-09-30 | 4.7 M |
Astrana Health's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.05 B.Market Cap |
|
Astrana Health's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.10 | 0.11 | |
| Return On Capital Employed | 0.12 | 0.12 | |
| Return On Assets | 0.07 | 0.07 | |
| Return On Equity | 0.10 | 0.10 |
Determining Astrana Health's profitability involves analyzing its financial statements and using various financial metrics to determine if Astrana Health is a good buy. For example, gross profit margin measures Astrana Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Astrana Health's profitability and make more informed investment decisions.
Evaluate Astrana Health's management efficiency
Astrana Health has return on total asset (ROA) of 0.0449 % which means that it generated a profit of $0.0449 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1026 %, meaning that it created $0.1026 on every $100 dollars invested by stockholders. Astrana Health's management efficiency ratios could be used to measure how well Astrana Health manages its routine affairs as well as how well it operates its assets and liabilities. The Astrana Health's current Return On Tangible Assets is estimated to increase to 0.11. The Astrana Health's current Return On Capital Employed is estimated to increase to 0.12. As of now, Astrana Health's Non Currrent Assets Other are increasing as compared to previous years. The Astrana Health's current Other Current Assets is estimated to increase to about 18.3 M, while Other Assets are projected to decrease to under 12.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.79 | 8.26 | |
| Tangible Book Value Per Share | 1.29 | 1.23 | |
| Enterprise Value Over EBITDA | 14.86 | 8.74 | |
| Price Book Value Ratio | 2.95 | 4.22 | |
| Enterprise Value Multiple | 14.86 | 8.74 | |
| Price Fair Value | 2.95 | 4.22 | |
| Enterprise Value | 1.8 B | 1 B |
Understanding the operational decisions made by Astrana Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta 1.238 |
Basic technical analysis of Astrana Stock
As of the 3rd of December, Astrana Health shows the Standard Deviation of 3.52, risk adjusted performance of 0.0027, and Mean Deviation of 1.99. Astrana Health technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Astrana Health's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Astrana Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Astrana Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Astrana Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Astrana Health's Outstanding Corporate Bonds
Astrana Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Astrana Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Astrana bonds can be classified according to their maturity, which is the date when Astrana Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| US03765HAB78 Corp BondUS03765HAB78 | View | |
| US03765HAE18 Corp BondUS03765HAE18 | View | |
| US03765HAD35 Corp BondUS03765HAD35 | View | |
| US03765HAF82 Corp BondUS03765HAF82 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US03762UAD72 Corp BondUS03762UAD72 | View | |
| Apollo Investment 525 Corp BondUS03761UAG13 | View |
Understand Astrana Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Astrana Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0027 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 1.99 | |||
| Coefficient Of Variation | (14,890) | |||
| Standard Deviation | 3.52 | |||
| Variance | 12.41 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.56) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 26.75 | |||
| Value At Risk | (3.68) | |||
| Potential Upside | 5.28 | |||
| Skewness | (3.08) | |||
| Kurtosis | 17.43 |
| Risk Adjusted Performance | 0.0027 | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 1.99 | |||
| Coefficient Of Variation | (14,890) | |||
| Standard Deviation | 3.52 | |||
| Variance | 12.41 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.56) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 26.75 | |||
| Value At Risk | (3.68) | |||
| Potential Upside | 5.28 | |||
| Skewness | (3.08) | |||
| Kurtosis | 17.43 |
Consider Astrana Health's intraday indicators
Astrana Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Astrana Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Astrana Health Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 12th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 15th of July 2024 Other Reports | ViewVerify |
Astrana Stock media impact
Far too much social signal, news, headlines, and media speculation about Astrana Health that are available to investors today. That information is available publicly through Astrana media outlets and privately through word of mouth or via Astrana internal channels. However, regardless of the origin, that massive amount of Astrana data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Astrana Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Astrana Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Astrana Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Astrana Health alpha.
Astrana Health Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Astrana Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Astrana Health Corporate Management
| WaiChow MD | Chief Officer | Profile | |
| Rita Pew | Vice Operations | Profile | |
| Carlos MD | Chief Texas | Profile | |
| CPA CGMA | Chief Officer | Profile |
Already Invested in Astrana Health?
The danger of trading Astrana Health is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Astrana Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Astrana Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Astrana Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Astrana Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share 1.3 | Revenue Per Share 36.415 | Quarterly Revenue Growth 0.375 | Return On Assets 0.0449 |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Astrana Health's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.